Primary progressive multiple sclerosis: progress and challenges

被引:45
作者
Rice, Claire M. [1 ]
Cottrell, David [2 ]
Wilkins, Alastair [3 ]
Scolding, Neil J. [4 ]
机构
[1] Univ Bristol, Inst Clin Neurosci, Frenchay Hosp, Bristol BS16 1LE, Avon, England
[2] North Bristol Trust, Frenchay Hosp, Dept Neurol, Bristol, Avon, England
[3] Univ Bristol, Dept Neurol, Frenchay Hosp, Bristol BS16 1LE, Avon, England
[4] Univ Bristol, Dept Neurol, Inst Clin Neurosci, Frenchay Hosp, Bristol BS16 1LE, Avon, England
关键词
Multiple Sclerosis; MESENCHYMAL STEM-CELLS; HUMAN BONE-MARROW; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PLACEBO-CONTROLLED TRIAL; SPINAL-CORD-INJURY; STROMAL CELLS; FUNCTIONAL RECOVERY; DOUBLE-BLIND; NATURAL-HISTORY; OLIGODENDROCYTE PROGENITOR;
D O I
10.1136/jnnp-2012-304140
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Primary progressive multiple sclerosis (MS) has long been recognised as presenting great difficulties to our management of what is increasingly a treatable neurological disease. Here we review some basic and clinical aspects of primary progressive MS, and describe how the disorder in fact offers powerful insights and opportunities for better understanding multiple sclerosis, and from a practical perspective an invaluable clinical substrate for studying and treating progressive disability in MS. Difficult hurdles remain, however, and these too are reviewed.
引用
收藏
页码:1100 / 1106
页数:7
相关论文
共 107 条
  • [1] Remyelination of the spinal cord following intravenous delivery of bone marrow cells
    Akiyama, Y
    Radtke, C
    Honmou, O
    Kocsis, JD
    [J]. GLIA, 2002, 39 (03) : 229 - 236
  • [2] Akiyama Y, 2002, J NEUROSCI, V22, P6623
  • [3] Alves H, 2009, J CELL MOL MED
  • [4] Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
    Antel, Jack
    Antel, Samson
    Caramanos, Zografos
    Arnold, Douglas L.
    Kuhlmann, Tanja
    [J]. ACTA NEUROPATHOLOGICA, 2012, 123 (05) : 627 - 638
  • [5] Human Bone Marrow-Derived Mesenchymal Stem Cells Induce Th2-Polarized Immune Response and Promote Endogenous Repair in Animal Models of Multiple Sclerosis
    Bai, Lianhua
    Lennon, Donald P.
    Eaton, Valerie
    Maier, Kari
    Caplan, Arnold I.
    Miller, Stephen D.
    Miller, Robert H.
    [J]. GLIA, 2009, 57 (11) : 1192 - 1203
  • [6] CD133 Identifies a Human Bone Marrow Stem/Progenitor Cell Sub-population With a Repertoire of Secreted Factors That Protect Against Stroke
    Bakondi, Benjamin
    Shimada, Issei S.
    Perry, Anthony
    Munoz, James R.
    Ylostalo, Joni
    Howard, Alan B.
    Gregory, Carl A.
    Spees, Jeffrey L.
    [J]. MOLECULAR THERAPY, 2009, 17 (11) : 1938 - 1947
  • [7] Axonal protection using flecainide in experimental autoimmune encephalomyelitis
    Bechtold, DA
    Kapoor, R
    Smith, KJ
    [J]. ANNALS OF NEUROLOGY, 2004, 55 (05) : 607 - 616
  • [8] The relationship between relapse, impairment and disability in multiple sclerosis
    Bennetto, L.
    Burrow, J.
    Sakai, H.
    Cobby, J.
    Robertson, N. P.
    Scolding, N.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (10) : 1218 - 1224
  • [9] Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE
    Black, Joel A.
    Liu, Shujun
    Hains, Bryan C.
    Saab, Carl Y.
    Waxman, Stephen G.
    [J]. BRAIN, 2006, 129 : 3196 - 3208
  • [10] Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases
    Burt, Richard K.
    Loh, Yvonne
    Pearce, William
    Beohar, Nirat
    Barr, Walter G.
    Craig, Robert
    Wen, Yanting
    Rapp, Jonathan A.
    Kessler, John
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (08): : 925 - 936